Rituximab and bilateral HSV epithelial keratitis in a patient with mucous membrane pemphigoid

BACKGROUND: B cell depleting therapy is widely used for lymphoproliferative diseases and immune-mediated disorders, including mucous membrane pemphigoid. The latter is an autoimmune blistering disease affecting predominantly the mucosae potentially associated with devastating complications. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernauer, W., Schuler, S., Borradori, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107448/
https://www.ncbi.nlm.nih.gov/pubmed/30141181
http://dx.doi.org/10.1186/s12348-018-0153-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6107448/
https://www.ncbi.nlm.nih.gov/pubmed/30141181
http://dx.doi.org/10.1186/s12348-018-0153-8

Ejemplares similares